BPA for ocaliva

Ended Awarded Jan 20, 2017 Last action Dec 27, 2021

Contract number: VA797P17A0002
Awardee: Intercept Pharmaceuticals Inc. UEI GHNKCLBJRMK7
Awarding agency: National Acquisition Center Headquarters, Department of Veterans Affairs
Task orders: 4 $53,682 obligated

Award facts

Opportunity: VA797P12Q0002 Solicitation number
Combined order value: $53,682 Current and potential, with all options
Last date to order 100% complete: Jan 19, 2022
IDV ceiling 1% used: $4,200,000.00
Award type: Single award
Who can order: Only the awarding agency
Contracting staff: Deb Fassl
NAICS code: 325412 Pharmaceutical Preparation Manufacturing
PSC: 6505 Drugs And Biologicals
Set-aside: No set-aside
Competition: Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing: Firm Fixed Price

Award details come from SAM.gov/FPDS.

Task order	Ordering agency	Obligated	Awarded
Express report: pharmacy ordering officer orders for ocaliva for FY19 36C24719K0039	Veterans Integrated Service Network 7 (VHA)	$4,363	May 31, 2019
Express report: for pharmacy ordering officer orders for ocaliva for FY18 36C24718K0021	Veterans Integrated Service Network 7 (VHA)	$15,187	Oct 19, 2017
Express report: pharmaceutical orders 36C24618K0395	Veterans Integrated Service Network 6 (VHA)	$4,266	Aug 23, 2017
Express report: for pharmacy ordering officer orders for pharmaceuticals for FY17 36C24718K0139	Veterans Integrated Service Network 7 (VHA)	$29,867	Mar 14, 2017

Action	Obligated	Date
Supplemental Agreement for work within scope P00010 · 2022 public law pricing updates	$0	Dec 27, 2021
Supplemental Agreement for work within scope P00009 · 2021 public law pricing updates	$0	Dec 7, 2020
Exercise an Option P00008 · Exercise the 4TH and final option year with no price changes	$0	Nov 20, 2020
Supplemental Agreement for work within scope P00007 · 2020 public law pricing updates	$0	Dec 31, 2019
Exercise an Option P00006 · Exercise third option year	$0	Dec 11, 2019
Exercise an Option P00005 · Exercise second option year	$0	Jan 17, 2019
Supplemental Agreement for work within scope P00004 · 2019 public law updates	$0	Dec 27, 2018
Exercise an Option P00003 · Exercise option year	$0	Jan 4, 2018
Supplemental Agreement for work within scope P00002 · 2018 public law updates	$0	Dec 27, 2017
Other Administrative Action P00001 · Revised ocaliva ordering forms and updated address	$0	Oct 27, 2017
Original award	$0	Jan 20, 2017

Show all 11

VA797P17A0002 was awarded to Intercept Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on January 20, 2017.

Orders under VA797P17A0002 have obligated $53,682. VA797P17A0002's own ceiling is $4,200,000.

4 orders have been placed under VA797P17A0002, the latest on May 31, 2019.

VA797P17A0002 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Yes. VA797P17A0002 is a blanket purchase agreement under V797D70027, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

The extent of competition for VA797P17A0002 was full and open competition. The government received 1 offer.

On GovTribe

Try for free Login